logo
episode-header-image
Oct 2025
42m 51s

Episode 452: ESMO 2025 - DV+ toripalimab...

THE UROMIGOS
About this episode

Matt Galsky discusses the exciting Presidential session data from the Chinese phase 3 of DV+ toripalimab in advanced urothelial cancer.

Up next
Feb 28
Episode 485: ASCO GU 2026 - LITESPARK 011: Len/Belzu vs Cabo
summaryThis detailed discussion covers the latest phase three trial results in kidney cancer, focusing on LITESPARK 011: Belzutifan and Levatnib combination versus Cabozantinib. Brian, Tom and Bob Motzer analyze efficacy, safety, and implications for treatment sequencing. 
31m 27s
Feb 28
Episode 484: ASCO GU 2026 - LITESPARK 022: Adjuvant Pembro + Belzutifan in RCC
This in-depth discussion explores the latest advancements in adjuvant kidney cancer treatment, focusing on the recent phase 3 trial results of Belzutifan combined with Pembrolizumab, mechanistic insights, biomarker development, and future research directions. 
36m 53s
Feb 28
Episode 482: ASCO GU 2026 - SUNRISE 2
The conversation revolves around the Sunrise 2 trial, a study investigating the efficacy of TAR-200 combined with cetrilimab versus traditional chemoradiotherapy in muscle-invasive bladder cancer. The discussion covers the study's design, patient population, results, and implicat ... Show More
33m 23s
Recommended Episodes
Sep 2023
Myeloma - Prof Jorge Sierra
Prof Jorge Sierra provides an overview of myeloma, delving into its clinical aspects and sharing his personal passion for the disease. Together with host Prof. Konstanze Döhner, they explore myeloma's treatment challenges and advancements. Prof. Sierra also offers valuable advice ... Show More
23m 36s
Jul 2025
The 6-1-1 Podcast Ep. 9: Pedro Martinez Part 2
Pedro Martinez joins Jimmy Rollins & Ryan Howard to talk pitchers in today’s game and his time with the Phillies! To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastcho ... Show More
43m 42s
Jan 2024
EP 125 - New Perspectives on Stuttering - Part 1
<p>This podcast episode is all about new perspectives on stuttering. This is the first of a two-part series, so be sure to tune in for part two in two weeks. Listen to part one to learn more and don't forget to check out the links and resources by accessing the show notes here: h ... Show More
13m 52s
Oct 2025
The Mystery, Again - Mariano Horenstein
"X". Calle Alcalá, Madrid. Photograph by Ana M. Martín Solar. With the evocative title “Once Again, the Mystery”, the Argentine psychoanalyst Mariano Horenstein poses the equally enigmatic question: How do we listen to the language of sexuality today? Through an exploration of th ... Show More
35m 59s
Jun 2023
Pivotal Stroke Trials Presented at this Year's ESOC
Dr. Seemant Chaturvedi discusses this year's European Stroke Organization Conference and pivotal trials that were presented during the conference. Read the related content on the ESOC Plenary Highlights page. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more ... Show More
2m 57s
Sep 2020
Introduction
A brief overview of the podcast, and the motivation behind the podcast. If you're looking for a comedic approach to otherwise bleak topics you've found the perfect spot! We're going to talk about how cannabis can help with the side effects of chemo and radiation, while directing ... Show More
8m 46s
Jul 2020
We will be discussing narcissistic personality disorder and how to cope.
First part of the episode is a quick introduction; the second part is not quite SFW and is lighthearted discussion of Spanish beaches.... 
14m 15s
Jun 2021
Manchester United Pod - Ole Season Review | MUGA
Elijah is joined by Morayo and Michael as they review the season from the perspective of the manager Ole Gunnar Solskjaer. Sign up to Fanslide https://play.fanslide.com/wcQYrlAUZgb Search for TouchlineFracas on the friends page to enter our Touchline Specific competition Learn mo ... Show More
1h 14m
Aug 2024
Chapter 9: Hematology-Oncology - Miscellaneous Oncology
We conclude this chapter discussing oncologic syndromes, paraneoplastic associations, and review of screening guidelines. 
12m 3s